Evofem Biosciences Inc EVFM shares are trading higher on Monday after Piper Sandler initiated coverage on the company's stock with an Outperform rating and announced an $11 price target.
Evofem Biosciences provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products.
Evofem products that are in development phase include Amphora primarily for the prevention of pregnancy and prevention of ur
Evofem Biosciences shares were trading up 6.19% at $3.52 on Monday. The stock has a 52-week high of $7.50 and a 52-week low of $3.20.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
